Treatment satisfaction in patients receiving dupilumab for moderate-to-severe atopic dermatitis

被引：0
|
作者：
Lans, A. [1 ]
Van der Schaft, J. [1 ]
Bakker, D. [1 ]
Ariens, L. [1 ]
Thijs, J. H. [1 ]
De Bruin-Weller, M. S. [1 ]
Balak, D. M. W. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Utrecht, Netherlands
来源：
ALLERGY | 2019年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
OA0141
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [41] Assessment of potential predictive factors of dupilumab response in patients with moderate-to-severe atopic dermatitis
    Mele-Ninot, Gemma
    Curto-Barredo, Laia
    Bonfill-Orti, Montserrat
    Exposito-Serrano, Vicente
    Munera-Campos, Monica
    Figueras Nart, Ignasi
    Riquelme-Mc Loughlin, Constanza
    Gomez-Armayones, Sara
    Spertino, Jorge
    Serra-Baldrich, Esther
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024, 65 (02) : 153 - 162
  • [42] Dupilumab in Combination With JAK Inhibitor for Refractory Moderate-to-Severe Atopic Dermatitis
    Song, Xiaoting
    Liu, Bo
    Peng, Chengyue
    Tan, Yen
    Zhao, Zuotao
    DERMATOLOGIC THERAPY, 2024, 2024 (01)
  • [43] A study into the drug dupilumab in Japanese adults with moderate-to-severe atopic dermatitis
    不详
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (01) : E4 - E4
  • [44] Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis
    Berdyshev, Evgeny
    Goleva, Elena
    Bissonnette, Robert
    Bronova, Irina
    Bronoff, Anna Sofia
    Richers, Brittany N.
    Garcia, Shannon
    Ramirez-Gama, Marco
    Taylor, Patricia
    Praestgaard, Amy
    Agueusop, Inoncent
    Jurvilliers, Pauline
    Boguniewicz, Mark
    Levit, Noah A.
    Rossi, Ana B.
    Zhang, Annie
    Leung, Donald Y. M.
    ALLERGY, 2022, 77 (11) : 3388 - 3397
  • [45] Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Villegas, Susan C.
    Dima, Lorena
    AMERICAN JOURNAL OF THERAPEUTICS, 2023, 30 (02) : E117 - E125
  • [46] Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Diana Bernardo
    Thomas Bieber
    Tiago Torres
    American Journal of Clinical Dermatology, 2023, 24 : 753 - 764
  • [47] Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Bernardo, Diana
    Bieber, Thomas
    Torres, Tiago
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (05) : 753 - 764
  • [48] Dupilumab treatment reduces total IgE levels in patients 6 months and older with moderate-to-severe atopic dermatitis
    Siegfried, Elaine C.
    Cork, Michael J.
    Boguniewicz, Mark
    Deleuran, Mette
    Simpson, Eric L.
    Chen, Zhen
    Clearfield, Drew
    Shah, Parul
    Rodriguez Marco, Ainara
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [49] Dupilumab but not cyclosporine treatment shifts the microbiome toward a healthy skin flora in patients with moderate-to-severe atopic dermatitis
    Hartmann, Jan
    Moitinho-Silva, Lucas
    Sander, Nicole
    Harder, Inken
    Haesler, Robert
    Rodriguez, Elke
    Haufe, Eva
    Kleinheinz, Andreas
    Abraham, Susanne
    Heratizadeh, Annice
    Weisshaar, Elke
    Schaekel, Knut
    Handrick, Christiane
    Augustin, Matthias
    Wollenberg, Andreas
    Staubach-Renz, Petra
    Ertner, Konstantin
    Sticherling, Michael
    Schwarz, Beate
    Quist, Sven
    Wiemers, Franca
    Schenck, Florian
    Wildberger, Julia
    Tittmann, Lukas
    Lieb, Wolfgang
    Schmitt, Jochen
    Werfel, Thomas
    Weidinger, Stephan
    ALLERGY, 2023, 78 (08) : 2290 - 2300
  • [50] Dupilumab Treatment Reduces Total IgE Levels in Patients 6 Months and Older with Moderate-to-Severe Atopic Dermatitis
    Siegfried, Elaine
    Cork, Michael
    Boguniewicz, Mark
    Deleuran, Mette
    Simpson, Eric
    Chen, Zhen
    Clearfield, Drew
    Shah, Parul
    Rodriguez-Marco, Ainara
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB149 - AB149
12345